Latest news

Thumbnail image for US approves first Herceptin biosimilar

US approves first Herceptin biosimilar

Mylan and Biocon’s Ogivri is the first biosimilar of Herceptin to win US approval, for certain breast cancer and metastatic stomach cancers.

4th December 2017

Thumbnail image for NHS A&E performance target remains well under par

NHS A&E performance target remains well under par

December has kicked off with NHS hospital performance against the four hour A&E target standing at just 82.45 percent - 12.55 percentage points lower than the 95 percent standard, reports the Royal College of Emergency Medicine (RCEM).

4th December 2017

Thumbnail image for Orphan status for Shire’s experimental UC drug

Orphan status for Shire’s experimental UC drug

US regulators have granted Shire’s investigational therapy SHP647 orphan status for the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).

1st December 2017

Thumbnail image for NHS England confirms cull of low-value treatments

NHS England confirms cull of low-value treatments

Fish oil, herbal remedies and homeopathy are among ‘low-value’ treatments that NHS England is recommending are no longer provided by the NHS, in a move it says should generate millions of pounds of savings each year.

1st December 2017

Thumbnail image for ViiV trials drug for HIV prevention in women

ViiV trials drug for HIV prevention in women

ViiV Healthcare has initiated a Phase III study exploring the efficacy of long-acting cabotegravir for the prevention of HIV infection in sexually active women.

30th November 2017

Previous  --   5 6 7 8 9 10 11 12 13 14   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download